Collectively, our results indicate that SOX6 overexpression promotes the glycolytic process and increases the content of long-chain phospholipids such as PE/PC by disrupting fatty acid transport and fatty acid metabolism to promote tumor invasion in C1/C2 melanoma cells. Here, SOX6 is linked to melanoma.